Affordable Care Act, Congressional Committees

McDermott+ Check-Up – June 27, 2025

McDermott+ on 6/27/2025

Senate Reconciliation Process Continues. Republicans are adjusting language to comply with Senate rules and appease various wings of the party....more

Healthcare Preview for the Week of: June 16, 2025

McDermott+ on 6/17/2025

The House is out this week for the Juneteenth holiday, but the Senate will be in town through Wednesday. We expect these three days to be significant because the Senate Finance Committee has announced that it intends to...more

Holland & Knight Health Dose: March 11, 2025

Holland & Knight LLP on 3/12/2025

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more

Health Dose: Post-Election Edition

Holland & Knight LLP on 11/12/2024

Holland & Knight's Healthcare & Life Sciences Policy Team regularly provides updates through our weekly Health Dose. This special Health Dose: Post-Election Edition is intended to outline the short- and long-term potential...more

Holland & Knight Health Dose: March 12, 2024

Holland & Knight LLP on 3/14/2024

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more

The Doctor (Fix) Is In: Regulatory Implications of the Minibus Healthcare Package

McDermott+ on 3/7/2024

Last Sunday, Congress released the text of a minibus package, which will likely be signed into law by tomorrow. While the bill’s primary purpose is to keep the government open, it also includes healthcare extenders through...more

Holland & Knight Health Dose: February 27, 2024

Holland & Knight LLP on 2/28/2024

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more

McDermottPlus Check-Up: May 19, 2023

McDermott+ on 5/19/2023

The House and Senate were both in session this week, with significant healthcare activity at the committee level. The House Ways & Means Committee met to discuss healthcare price transparency, and the Ways & Means Health...more

Holland & Knight Health Dose: December 6, 2022

Holland & Knight LLP on 12/7/2022

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. This week's topics include: -...more

Beltway Buzz - August 2022

Ogletree, Deakins, Nash, Smoak & Stewart,... on 8/8/2022

Senate Scrambles Ahead of Summer Escape. While members of the U.S. House of Representatives returned home for the August congressional recess, the U.S. Senate remained in Washington, D.C., this week to wrap up some...more

Alston & Bird Health Care Week in Review - April 2022 #2

Alston & Bird on 4/11/2022

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

Federal Government Funded for Fiscal Year 2020; Surprise Billing and Comprehensive Drug Pricing Legislation Postponed Until 2020

King & Spalding on 12/31/2019

Last Friday, President Trump signed into law two bipartisan legislative packages that included all twelve Fiscal Year 2020 funding bills. Comprehensive surprise billing and drug pricing legislation were not included in the...more

House Committees Hold Hearings to Protect the Affordable Care Act

King & Spalding on 2/14/2019

Last week, three House Committees held hearings about protecting the Affordable Care Act (ACA), receiving testimony from patient advocates, researchers, and ACA supporters. Members of both parties supported preserving...more

Top 10 Things Employers Need To Know About Midterm Election Results

Fisher Phillips on 11/7/2018

As many predicted, Democrats recaptured the House for the first time in eight years in yesterday’s midterm elections, while Republicans retained and strengthened their grip on the Senate. That will lead to a dynamic in...more

Trump Administration: 2017 Recap and 2018 Outlook

Akin Gump Strauss Hauer & Feld LLP on 1/17/2018

On January 20, 2017, businessman Donald J. Trump was sworn in as the 45th President of the United States following a contentious and unconventional 2016 presidential election. Republicans also successfully maintained control...more

Beltway Buzz - September, 2017 #3

Ogletree, Deakins, Nash, Smoak & Stewart,... on 9/18/2017

He Said, They Said. Over a Wednesday night dinner consisting of the unusual combination of Chinese food and chocolate pie, President Trump and Democratic congressional leaders Charles Schumer (D-NY) and Nancy Pelosi (D-CA)...more

26 Days: Congress and Health Care as FY 2017 Comes to a Close

Epstein Becker & Green on 9/6/2017

Congress returns from August recess today, facing a daunting workload to complete before the end of the current fiscal year (FY) on September 30. Big picture issues include raising the national debt ceiling and passing a...more

ACA Brief: Path to Repeal – ACA Nearing Its Lifetime Limit?

Eversheds Sutherland (US) LLP on 1/18/2017

This ACA Brief is the first in a series of installments that will closely track congressional and administrative actions relating to ACA provisions that impact large employer-sponsored plans. On January 12, the U.S....more

[Webinar] What to Expect in Trump's First 100 Days - January 18th, 11:00am ET

BakerHostetler on 1/6/2017

After years of gridlock, Congress is poised to unleash a flurry of legislative activity early in 2017. The agenda is jam-packed as the Republican-led Congress targets major changes to the Affordable Care Act, Dodd-Frank,...more

Health Care Update - February 2016 #3

Mintz - ML Strategies on 2/17/2016

The Administration is Ramping Up Drug Pricing Response - The President’s budget makes clear for all to see that the Administration wants to do something related to drug pricing. Unfortunately for the Administration,...more

Congressional Oversight in the 114th Congress: What to Expect in 2016

King & Spalding on 1/26/2016

While it is likely that the Obama Administration will continue to be a major focus of GOP-led oversight inquiries in 2016, industry stakeholders, particularly those affected by legislation or proposed regulations, should also...more

Health Care Update - November 2015 #2

Mintz - ML Strategies on 11/18/2015

FDA Hosts Genome Scientists For Next-Generation Sequencing Conference - Last week, the Food and Drug Administration (FDA) hosted genome scientists from across the nation at its campus in White Oak, Maryland. Two public...more

Health Care Update - November 2015

Mintz - ML Strategies on 11/4/2015

Ways & Means Leadership Changes – Health Policy Implications Looming: As Congress pushes forward with a two-year budget deal, and new Speaker Paul Ryan begins his tenure as the top Republican in the House of...more

Health Care Update - October 2015

Mintz - ML Strategies on 10/29/2015

Senate Working Group Pressing Forward on Telehealth - As Congress focuses on bigger picture policy decisions, including broad budget negotiations and raising the debt ceiling, there are some exciting developments on the...more

Does Invalidation of 340B Orphan Drug Rule Doom HRSA’s Guidance?

Mintz - Health Care Viewpoints on 10/21/2015

Our recent post on HRSA’s Omnibus Proposed Guidance for the 340B Drug Discount Program (Proposed Guidance) noted that since the DC District Court had yet to rule on the validity of HRSA’s “interpretive” 340B orphan drug rule,...more

Patient Protection and Affordable Care Act (PPACA) › Congressional Committees

"My best business intelligence, in one easy email…"